Search

Gerald Proehl Phones & Addresses

  • 405 5Th St, Milan, IL 61264 (309) 787-5696
  • Hamel, MN
  • San Diego, CA
  • Hamel, MN
  • 405 5Th St E, Milan, IL 61264 (309) 267-3065

Work

Position: Administrative Support Occupations, Including Clerical Occupations

Education

Degree: Associate degree or higher

Business Records

Name / Title
Company / Classification
Phones & Addresses
Gerald Proehl
Director
MDREJUVENA, INC
3525 Del Mar Hts Rd, San Diego, CA 92130
5810 Nancy Rdg Dr SUITE 100, San Diego, CA 92121
Gerald T. Proehl
President
COVELLA PHARMACEUTICALS, INC
8510 Colonnade Ctr Dr, Raleigh, NC 27615
12636 High Blf Dr, San Diego, CA 92130
3721 Vly Ctr Dr, San Diego, CA 92130
Gerald T Proehl
President, Director , Chief Executive Offi, CEO
SANTARUS, INC
Nonclassifiable Establishments · Mfg Pharmaceutical Preparations · Pharmaceutical Preparations · Pharmaceutical Research and Development · Druggists' Goods Merchant Whols
8510 Colonnade Ctr Dr STE 400, Raleigh, NC 27615
10590 W Ocean Air Dr, San Diego, CA 92130
2338 W Royal Palm Rd STE J, Phoenix, AZ 85021
3611 Vly Ctr Dr, San Diego, CA 92130
(858) 314-5700, (858) 523-9308, (858) 314-5701, (858) 314-5744

Publications

Us Patents

Combination Of Proton Pump Inhibitor And Sleep Aid

View page
US Patent:
20050244517, Nov 3, 2005
Filed:
Nov 5, 2004
Appl. No.:
10/982369
Inventors:
Warren Hall - San Diego CA, US
Kay Olmstead - San Diego CA, US
Gerald Proehl - San Diego CA, US
International Classification:
A61K031/5513
A61K031/496
A61K031/4439
A61K031/519
A61K031/515
A61K035/78
US Classification:
424733000, 514338000, 514221000, 514262100, 514303000, 514253040, 514270000
Abstract:
Pharmaceutical compositions comprising a proton pump inhibitor, one or more buffering agent and a sleep aid are described. Methods are described for treating gastric acid related disorders and inducing sleep, using pharmaceutical compositions comprising a proton pump inhibitor, a buffering agent, and a sleep aid.

Combination Of Proton Pump Inhibitor, Buffering Agent, And Nonsteroidal Anti-Inflammatory Drug

View page
US Patent:
20050249806, Nov 10, 2005
Filed:
Feb 4, 2005
Appl. No.:
11/051260
Inventors:
Gerald Proehl - San Diego CA, US
Kay Olmstead - San Diego CA, US
Warren Hall - Del Mar CA, US
International Classification:
A61K009/48
A61K031/4439
A61K009/20
US Classification:
424464000, 514338000
Abstract:
Pharmaceutical compositions comprising a proton pump inhibitor, one or more buffering agent and a nonsteroidal anti-inflammatory drug are described. Methods are described for treating gastric acid related disorders and treating inflammatory disorders, using pharmaceutical compositions comprising a proton pump inhibitor, a buffering agent, and a nonsteroidal anti-inflammatory drug.

Pharmaceutical Formulations Useful For Inhibiting Acid Secretion And Methods For Making And Using Them

View page
US Patent:
20050266071, Dec 1, 2005
Filed:
May 25, 2005
Appl. No.:
11/138763
Inventors:
Kay Olmstead - San Diego CA, US
Warren Hall - Del Mar CA, US
Gerald Proehl - San Diego CA, US
International Classification:
A61K031/4439
A61K009/48
US Classification:
424451000, 514338000
Abstract:
The present invention relates to pharmaceutical formulations comprising at least one acid-labile proton pump inhibiting agent and at least one antacid, which have improved bioavailability, chemical stability, physical stability, dissolution profiles, disintegration times, safety, as well as other improved pharmacokinetic, pharmacodynamic, chemical and/or physical properties. The present invention is directed to methods, kits, combinations, and compositions for treating, preventing or reducing the risk of developing a gastrointestinal disorder or disease, or the symptoms associated with, or related to, a gastrointestinal disorder or disease in a subject in need thereof.

Pharmaceutical Formulations Useful For Inhibiting Acid Secretion And Methods For Making And Using Them

View page
US Patent:
20060147522, Jul 6, 2006
Filed:
Nov 28, 2005
Appl. No.:
11/287888
Inventors:
Kay Olmstead - San Diego CA, US
Warren Hall - Del Mar CA, US
Gerald Proehl - San Diego CA, US
International Classification:
A61K 31/4439
A61K 9/20
A61K 33/00
US Classification:
424464000, 424717000, 514338000
Abstract:
The present invention relates to pharmaceutical formulations comprising at least one acid-labile proton pump inhibiting agent and at least one antacid, which have improved bioavailability, chemical stability, physical stability, dissolution profiles, disintegration times, safety, as well as other improved pharmacokinetic, pharmacodynamic, chemical and/or physical properties. The present invention is directed to methods, kits, combinations, and compositions for treating, preventing or reducing the risk of developing a gastrointestinal disorder or disease, or the symptoms associated with, or related to, a gastrointestinal disorder or disease in a subject in need thereof.

Combinations Of Proton Pump Inhibitors, Sleep Aids, Buffers And Pain Relievers

View page
US Patent:
20070292498, Dec 20, 2007
Filed:
Jun 15, 2007
Appl. No.:
11/818869
Inventors:
Warren Hall - San Diego CA, US
Gerald Proehl - San Diego CA, US
International Classification:
A61K 9/48
A61K 31/44
A61P 1/00
US Classification:
424451000, 514341000
Abstract:
Pharmaceutical compositions comprising a proton pump inhibitor, one or more buffering agent, a sleep aid and acetaminophen, ibuprofen, aspirin or naproxen are described. Methods are described for treating gastric acid related disorders and inducing sleep, using pharmaceutical compositions comprising a proton pump inhibitor, a buffering agent, a sleep aid and a pain reliever.

Combination Of Proton Pump Inhibitor, Buffering Agent, And Prokinetic Agent

View page
US Patent:
20050239845, Oct 27, 2005
Filed:
Apr 15, 2005
Appl. No.:
11/107349
Inventors:
Gerald Proehl - San Diego CA, US
Warren Hall - Del Mar CA, US
Kay Olmstead - San Diego CA, US
Bonnie Hepburn - Escondido CA, US
International Classification:
A61K031/4439
US Classification:
514338000
Abstract:
Pharmaceutical compositions comprising a proton pump inhibitor, one or more buffering agent and a prokinetic agent are described. Methods are described for treating gastric acid related disorders, using pharmaceutical compositions comprising a proton pump inhibitor, a buffering agent, and a prokinetic agent.

Pharmaceutical Formulations Useful For Inhibiting Acid Secretion And Methods For Making And Using Them

View page
US Patent:
20190022131, Jan 24, 2019
Filed:
Sep 21, 2018
Appl. No.:
16/138859
Inventors:
- Bridgewater NJ, US
Warren Hall - Del Mar CA, US
Gerald T. Proehl - San Diego CA, US
Assignee:
Santarus, Inc. - Bridgewater NJ
International Classification:
A61K 33/00
A61K 33/08
A61K 9/48
A61K 31/4439
A61K 9/00
A61K 9/20
Abstract:
The present invention relates to pharmaceutical formulations comprising at least one acid-labile proton pump inhibiting agent and at least one antacid, which have improved bioavailability, chemical stability, physical stability, dissolution profiles, disintegration times, safety, as well as other improved pharmacokinetic, pharmacodynamic, chemical and/or physical properties. The present invention is directed to methods, kits, combinations, and compositions for treating, preventing or reducing the risk of developing a gastrointestinal disorder or disease, or the symptoms associated with, or related to, a gastrointestinal disorder or disease in a subject in need thereof.

Pharmaceutical Formulations Useful For Inhibiting Acid Secretion And Methods For Making And Using Them

View page
US Patent:
20150044303, Feb 12, 2015
Filed:
Aug 25, 2014
Appl. No.:
14/467741
Inventors:
- Raleigh NC, US
Warren Hall - Del Mar CA, US
Gerald T. Proehl - San Diego CA, US
International Classification:
A61K 33/00
A61K 33/08
A61K 9/48
A61K 31/4439
US Classification:
424692, 424717
Abstract:
The present invention relates to pharmaceutical formulations comprising at least one acid-labile proton pump inhibiting agent and at least one antacid, which have improved bioavailability, chemical stability, physical stability, dissolution profiles, disintegration times, safety, as well as other improved pharmacokinetic, pharmacodynamic, chemical and/or physical properties. The present invention is directed to methods, kits, combinations, and compositions for treating, preventing or reducing the risk of developing a gastrointestinal disorder or disease, or the symptoms associated with, or related to, a gastrointestinal disorder or disease in a subject in need thereof.
Gerald D Proehl from Milan, IL, age ~76 Get Report